| Literature DB >> 22590564 |
Silvia Ferrara1, Margherita Brugnoli, Angela De Bonis, Francesco Righetti, Francesco Delvillani, Gianni Dehò, David Horner, Federica Briani, Giovanni Bertoni.
Abstract
Pseudomonas aeruginosa is a highly adaptable bacterium that thrives in a broad range of ecological niches and can infect multiple hosts as diverse as plants, nematodes and mammals. In humans, it is an important opportunistic pathogen. This wide adaptability correlates with its broad genetic diversity. In this study, we used a deep-sequencing approach to explore the complement of small RNAs (sRNAs) in P. aeruginosa as the number of such regulatory molecules previously identified in this organism is relatively low, considering its genome size, phenotypic diversity and adaptability. We have performed a comparative analysis of PAO1 and PA14 strains which share the same host range but differ in virulence, PA14 being considerably more virulent in several model organisms. Altogether, we have identified more than 150 novel candidate sRNAs and validated a third of them by Northern blotting. Interestingly, a number of these novel sRNAs are strain-specific or showed strain-specific expression, strongly suggesting that they could be involved in determining specific phenotypic traits.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22590564 PMCID: PMC3349714 DOI: 10.1371/journal.pone.0036553
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
nstSGR distribution in PAO1 and PA14.
| Loci | nstSGR group | PAO1 | PA14 |
| Unique | A | 9 | − |
| B | − | 20 | |
| Conserved | C | 43 | − |
| D | 76 | 76 | |
| E | − | 72 | |
| Total | 220 | 128 | 168 |
Figure 1Classes of candidate sRNAs and their distribution within the nstSGR groups resulting from sRNA-Seq.
The histogram summarizes the data of Table S2. Candidate sRNAs identified by sRNA-Seq were categorized into five structural/functional classes (I, sRNAs; II, 5′-UTRs; III, asRNAs; IV, CRISPRs; V, sRNAs overlapping annotated ORFs) according to the criteria depicted in Figure S3 and distributed within each nstSGR group (A and B, unique in PAO1 or PA14, respectively; C and E, conserved in both strains but expressed in either PAO1 or PA14, respectively; D, conserved and expressed in both strains).
Figure 2Validation of candidate sRNAs expressed from unique nstSGR in either PAO1 or PA14.
A selection of nstSGRs listed in Table S2, unique in either PAO1 or PA14, were inspected by Northern blot for the expression of sRNAs. Total RNA was extracted from both PAO1 (○) and PA14 (•) grown in the same conditions as for sRNA-Seq. Equal amounts of RNA (8 µg) from both strains were blotted and probed with radiolabelled riboprobes (0002 and 0021) or oligos (Table S1) complementary to nstSGR regions with the highest read coverage, as detailed in Materials and Methods. Validated unique sRNAs in PAO1 or PA14 are shown in (A) and (B), respectively. For SPA0014, 0015, 0018, 0019, signals detected in both strains (dots on the left of PAO1 lanes) can be due to aspecific probe hybridization. The ladder of molecular weight markers is shared by (A) and (B). (nt): nucleotides.
Figure 3Validation of candidate sRNAs differentially expressed from conserved nstSGR.
A selection of conserved nstSGRs listed in Table S2 that were supposed to be differentially expressed between the two strains according to sRNA-Seq data, were inspected by Northern blot. Total RNA was extracted from both PAO1 (○) and PA14 (•) grown in the same conditions as for sRNA-Seq. 8 µg of RNA from both strains were blotted and probed with radiolabelled oligos (Table S1) complementary to nstSGR regions with the highest read coverage. Validated sRNAs which showed higher levels of expression in PAO1 or PA14 are shown in (A) and (B), respectively. The ladder of molecular weight markers is shared by (A) and (B). (nt): nucleotides.
Figure 4Validation of candidate sRNAs similarly expressed from conserved nstSGR.
A selection of conserved nstSGRs listed in Table S2 that were supposed to be similarly expressed between the two strains according to sRNA-Seq data, were inspected by Northern blot. Total RNA was extracted from both PAO1 (○) and PA14 (•) grown in the same conditions as for sRNA-Seq. Equal amounts of RNA (8 µg) from both strains were blotted and probed with radiolabelled oligos or riboprobes (0104, 0112, 0118, 0131, 0143, 0150 and 0157) (Table S1) complementary to nstSGR regions with the highest read coverage. nstSGRs SPA0072, 0085, 0092, and 0122, corresponding to PAO1 loci for the known sRNAs tmRNA, RsmZ, CrcZ, and Spot42, respectively, were included in this analysis as positive controls. 5S RNA served as loading control and molecular weight marker. The ladder of molecular weight markers is indicated on the left of each panel. (nt): nucleotides.
Candidate sRNAs validated by Northern blot.
| PAO1 | PA14 | |||||||
| nstSGR Group | nstSGR name | class | Flanking/Involved | strand | Flanking/Involved | strand | Notes | |
| Unique | A | SPA0002 | I | 2326/2327 | − |
| ||
| SPA0003 | I | 2729/2730 | + |
| ||||
| B | SPA0011 | I | 30840/ | + | 20 | |||
| SPA0012 | I | 39480/39500 | + |
| ||||
| SPA0013 | I | 44640/44650 | − | 40 | ||||
| SPA0014 | I | 49480/49500 | + |
| ||||
| SPA0015 | I | 60120/60130 | − |
| ||||
| SPA0016 | I | 72510/72520 | − |
| ||||
| SPA0017 | III |
| − |
| ||||
| SPA0018 | III | 22270 | + | 50 | ||||
| SPA0019 | III | 35720 | + |
| ||||
| SPA0021 | III | 59370 | + |
| ||||
| SPA0023 | III | 59840 | − | MRE | ||||
| SPA0025 | IV | 33360 | − | MRE;CRISPR-2 | ||||
| Conserved | C | SPA0027 | I |
| + | 55150/ |
| |
| SPA0038 | I | 2754/ | + |
|
| |||
| SPA0055 | III | 0667 | + | 08540/ |
| |||
| D | SPA0072 | I |
| − | 53560/53570 | + |
| |
| SPA0074 | I | 1429/ | + |
| − |
| ||
| SPA0077 | I |
| + |
| − | 50–70 | ||
| SPA0078 | I | 2421/2422 | − | 33370/33380 | + | 20–40 | ||
| SPA0079 | I | 2763/2764 | − | 28350/28360 | + |
| ||
| SPA0081 | I | 3069/3070 | − |
| + |
| ||
| SPA0084 | I | 3535/3536 | + | 18620/18630 | − | 70–50 | ||
| SPA0085 | I |
| − |
| + |
| ||
| SPA0086 | I | 3919/1920 | − | 13170/13190 | + | 70– | ||
| SPA0087 | I | 4033/ | + |
| − |
| ||
| SPA0092 | I |
| + |
| + | MRE; CrcZ | ||
| SPA0096 | I | 2751/2752 | − | 28520 | + | 50 | ||
| SPA0097 | I | 2771/2770 | + | 28250 | − |
| ||
| SPA0101 | II | 1244 | − | 48150 | + |
| ||
| SPA0102 | II |
| − |
| + | MRE | ||
| SPA0103 | II | 3229 | + | 22420 | − |
| ||
| SPA0104 | II |
| − |
| + |
| ||
| SPA0106 | II | 4133 | + |
| − |
| ||
| SPA0110 | II | 5473 | + | 72230 | + |
| ||
| SPA0111 | III |
| − | 01970 | − | 70–140 | ||
| SPA0112 | III | 0367 | − | 04820 | − |
| ||
| SPA0115 | III | 2759 | + | 28410 | − | 70 | ||
| SPA0116 | III | 2769 | + | 28290 | − |
| ||
| SPA0118 | III | 3350 | − |
| + |
| ||
| SPA0121 | III | 5480 | − | 72350 | − |
| ||
| SPA0122 | III | 5492 | − |
| − | 30– | ||
| SPA0124 | V | 1414 | + | 46160 | − |
| ||
| E | SPA0131 | I |
|
| − |
| ||
| SPA0135 | I | 2559/2560 | 31430/31440 | + |
| |||
| SPA0143 | II |
|
| + | 80 | |||
| SPA0145 | II |
|
| − |
| |||
| SPA0146 | II | 3261/3262 | 21830 | + |
| |||
| SPA0150 | II |
|
| + |
| |||
| SPA0155 | III |
|
| − | MRE | |||
| SPA0156 | III |
|
| − |
| |||
| SPA0157 | III |
|
| − | 120 | |||
| SPA0162 | III |
|
| − |
| |||
| SPA0165 | III | 1735 | 42100 | + |
| |||
| SPA0167 | III | 1166/ | 49330/ | − | 80 | |||
| SPA0168 | III |
|
| + | 30 | |||
nstSGR group as defined in Table 1: A and B, unique in PAO1 or PA14, respectively; C and E, conserved in both strains but expressed in either PAO1 or PA14, respectively; D, conserved and expressed in both strains.
Name or number (e.g. 2326 is PA2326, 30840 is PA14_30840) of loci in the PAO1 and PA14 genomes either overlapping (class II, 5′-UTR; III, asRNA; and V, sense sRNAs overlapping annotated ORFs) or flanking (class I, sRNA) the nstSGRs.
Annotated sRNAs, found by sRNA-Seq, used as a positive control in Northern blot validation experiments.
Upper (+) or lower (−) genomic DNA strand coincident with cDNA reads.
sRNA size predicted by sRNA-Seq. Single values indicates coherent results between PAO1 and PA14. Otherwise, two values (PAO1-PA14) are reported. Values are indicated in bold whenever confirmed by Northern blotting. MRE: Multiple Read Ends defined by non-overlapping reads scattered within the nstSGR. The name of sRNAs used as validation controls is also indicated.
Class assignment in PAO1. The corresponding nstSGR in PA14 was assigned to class V.